Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

Beijing Tongren Hospital80 enrolled

Overview

Chronic rhinitis (CR) is one of the most common nasal mucosal diseases in the world. In China, about 140 million people suffer from this disease. Chronic rhinitis can lead to severe economic and social burden, as well as the potential risk of developing other chronic diseases such as asthma and chronic sinusitis. Therefore, it is of great significance to explore the classification and treatment strategies of chronic rhinitis in order to improve the health level of Chinese people.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Determination of the Efficacy of Different Medications for Idiopathic Rhinitis Impact of Different Medications on Biomarkers of Idiopathic Rhinitis Safety and Tolerance of Different Medications for Idiopathic Rhinitis

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Not younger than 18 years old * Diagnosed as idiopathic rhinitis * Signed and volunteered for the study Exclusion Criteria: * Comorbid airway diseases including (but not limited to) upper airway infection, chronic rhinosinusitis, nasal polyps * Allergic to the medicines about to study * Having used oral glucocorticoids or antihistamine agents within 30 days of the enrollment

Locations (2)

Beijing Tongren Hospital

Beijing, Beijing Municipality, China

RECRUITING

Yifan Meng